4.5 Article

Discovery of an in Vivo Tool to Establish Proof-of-Concept for MAP4K4-Based Antidiabetic Treatment

期刊

ACS MEDICINAL CHEMISTRY LETTERS
卷 6, 期 11, 页码 1128-1133

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acsmedchemlett.5b00215

关键词

MAP4K4; HGK; ZC1; kinase inhibitor; MAP4K4 inhibitor; P-loop; PF-6260933

向作者/读者索取更多资源

Recent studies in adipose tissue, pancreas, muscle, and macrophages suggest that MAP4K4, a serine/threonine protein kinase may be a viable target for antidiabetic drugs. As part of the evaluation of MAP4K4 as a novel antidiabetic target, a tool compound, 16 (PF-6260933) and a lead 17 possessing excellent kinome selectivity and suitable properties were delivered to establish proof of concept in vivo. The medicinal chemistry effort that led to the discovery of these lead compounds is described herein together with in vivo pharmacokinetic properties and activity in a model of insulin resistance.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据